HCQS 200 is a prescription tablet containing 200 mg of Hydroxychloroquine, marketed by IPCA Laboratories Ltd and supplied in strips of 15 tablets. Its use for autoimmune conditions or malaria should be determined by a qualified healthcare professional.
Each HCQS 200 tablet contains 200 mg of Hydroxychloroquine as the active ingredient. Hydroxychloroquine has antimalarial and immunomodulatory properties and should be used only under professional supervision for approved indications.
Hydroxychloroquine may be prescribed to manage autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus. It is also used for certain forms of malaria, depending on the infecting organism and local drug resistance patterns.
The inclusion of Hydroxychloroquine in HCQS 200 does not make it suitable for all inflammatory, infectious, or immune-related conditions. A healthcare professional must determine if treatment is appropriate for each patient.
Take HCQS 200 exactly as prescribed by your healthcare professional. Dose, frequency, and duration may vary based on your condition and individual factors.
Take hydroxychloroquine tablets with food or milk to reduce gastrointestinal discomfort. Do not change the dose, extend treatment, or use for unapproved purposes without consulting your healthcare professional.
Do not stop or change your prescribed treatment without consulting your healthcare professional.
Before taking HCQS 200, inform your healthcare professional about your medical history and all medicines, supplements, and healthcare products you use, including cumulative exposure or prolonged treatment. Appropriate eye examinations may therefore be required before or during treatment, depending on the patient's individual risk and the healthcare professional's recommendations.
Hydroxychloroquine may affect heart rhythm and can prolong the QT interval. Inform your healthcare professional about any heart conditions, rhythm disorders, electrolyte issues, or medicines that may affect heart rhythm.
Discuss any kidney or liver problems, psoriasis, porphyria, blood disorders, or known allergies to Hydroxychloroquine or related medicines with your healthcare professional.
Seek prompt medical attention for any serious or unexpected reactions. Discuss questions about side effects, interactions, pregnancy, breastfeeding, or long-term monitoring with your healthcare professional.
HCQS 200 is a prescription medicine. Do not start this medication based on self-diagnosis or information from an e-commerce product page.
Do not use another person's prescription, share your medicine, or change your treatment based on another patient’s symptoms.
Do not assume hydroxychloroquine treats or prevents a condition unless supported by medical guidance and regulatory approval.
Store HCQS 200 as instructed with the original product. Keep tablets in their original packaging, below 25°C, and protect from unsuitable storage conditions, out of the reach of children.
Ipca Laboratories Ltd. markets HCQS 200, supplied in strips of 15 tablets, each containing 200 mg of Hydroxychloroquine.
This information is for general reference only. It does not replace a prescription, professional medical advice, diagnosis, treatment, monitoring, or official prescribing information. Approved uses and regulatory status may vary by country. Always follow the guidance of a qualified healthcare professional.